127 related articles for article (PubMed ID: 38220428)
41. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
[TBL] [Abstract][Full Text] [Related]
42. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
[TBL] [Abstract][Full Text] [Related]
43. CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.
Tsai HC; Su HL; Huang CY; Fong YC; Hsu CJ; Tang CH
Oncotarget; 2014 Jun; 5(11):3800-12. PubMed ID: 25003330
[TBL] [Abstract][Full Text] [Related]
44. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
[TBL] [Abstract][Full Text] [Related]
45. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
46. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
47. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.
Pruksakorn D; Teeyakasem P; Klangjorhor J; Chaiyawat P; Settakorn J; Diskul-Na-Ayudthaya P; Chokchaichamnankit D; Pothacharoen P; Srisomsap C
Int J Oncol; 2016 Sep; 49(3):903-12. PubMed ID: 27573585
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
[TBL] [Abstract][Full Text] [Related]
50. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
[TBL] [Abstract][Full Text] [Related]
51. Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR‑183/Ezrin pathway.
Zhang J; Yang W; Zhou YB; Xiang YX; Wang LS; Hu WK; Wang WJ
Mol Med Rep; 2018 Jul; 18(1):1104-1112. PubMed ID: 29845278
[TBL] [Abstract][Full Text] [Related]
52. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.
Zhao H; Guo M; Zhao G; Ma Q; Ma B; Qiu X; Fan Q
Int J Mol Med; 2012 Nov; 30(5):1013-20. PubMed ID: 22922800
[TBL] [Abstract][Full Text] [Related]
53. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway.
Lu S; Liao QS; Tang L
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304
[TBL] [Abstract][Full Text] [Related]
54. DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
Wang L; Liu W; Tang H; Xie X; Zou C; Wang Y; Gao Z; Yin J
Cancer Med; 2017 May; 6(5):982-993. PubMed ID: 28374915
[TBL] [Abstract][Full Text] [Related]
55. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
56. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach.
Shabani P; Izadpanah S; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):4783-4793. PubMed ID: 30450580
[TBL] [Abstract][Full Text] [Related]
57. PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective.
Sun C; Li S
J Cell Mol Med; 2021 Apr; 25(7):3175-3181. PubMed ID: 33675132
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
59. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.
Gao Y; Bai L; Shang G
Aging (Albany NY); 2020 Dec; 13(2):2668-2680. PubMed ID: 33411691
[TBL] [Abstract][Full Text] [Related]
60. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
Fan H; Lu S; Wang S; Zhang S
Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
